Device Closure of a Large Atrial Septal Defect in a Patient with Severe Pulmonary Arterial Hypertension after 1 Year Use of an Oral Endothelin Receptor Antagonist
Journal of Cardiovascular Ultrasound
;
: 140-144, 2013.
Artigo
em Inglês
| WPRIM
| ID: wpr-54460
ABSTRACT
The presence of severe pulmonary arterial hypertension (PAH) in patients with atrial septal defect (ASD) is still thought to preclude shunt closure, although there are several reports of good clinical outcomes after vasodilator therapy. We report the case of a young woman with ASD and severe PAH who was able to successfully undergo percutaneous shunt closure following 1 year use of the oral endothelin receptor antagonist, bosentan.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Sulfonamidas
/
Receptores de Endotelina
/
Comunicação Interatrial
/
Hipertensão Pulmonar
Limite:
Feminino
/
Humanos
Idioma:
Inglês
Revista:
Journal of Cardiovascular Ultrasound
Ano de publicação:
2013
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS